|
Mechanism5-HT1A receptor agonists |
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Epix Industries, Inc.
0 Patents (Medical) associated with Epix Industries, Inc.
100 Deals associated with Epix Industries, Inc.
100 Translational Medicine associated with Epix Industries, Inc.